KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Acquisitions (2016 - 2021)

Encompass Health (EHC) has disclosed Acquisitions for 9 consecutive years, with -$96.6 million as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Acquisitions changed N/A year-over-year to -$96.6 million, compared with a TTM value of -$96.6 million through Dec 2022, down 8881.82%, and an annual FY2021 reading of $15.9 million, changed N/A over the prior year.
  • Acquisitions was -$96.6 million for Q3 2021 at Encompass Health, down from $97.7 million in the prior quarter.
  • Across five years, Acquisitions topped out at $97.7 million in Q2 2021 and bottomed at -$96.6 million in Q3 2021.
  • Average Acquisitions over 4 years is $5.4 million, with a median of $3.4 million recorded in 2017.
  • The sharpest move saw Acquisitions skyrocketed 53.92% in 2017, then crashed 466.67% in 2020.
  • Year by year, Acquisitions stood at $2.2 million in 2017, then plummeted by 86.36% to $300000.0 in 2019, then plummeted by 466.67% to -$1.1 million in 2020, then plummeted by 8681.82% to -$96.6 million in 2021.
  • Business Quant data shows Acquisitions for EHC at -$96.6 million in Q3 2021, $97.7 million in Q2 2021, and -$1.1 million in Q4 2020.